BG104713A - Е-2-[4-(4-хлоро-1,2-дифенил-бут-1-енил) фенокси]-етанол и негови фармацевтични състави - Google Patents

Е-2-[4-(4-хлоро-1,2-дифенил-бут-1-енил) фенокси]-етанол и негови фармацевтични състави

Info

Publication number
BG104713A
BG104713A BG104713A BG10471300A BG104713A BG 104713 A BG104713 A BG 104713A BG 104713 A BG104713 A BG 104713A BG 10471300 A BG10471300 A BG 10471300A BG 104713 A BG104713 A BG 104713A
Authority
BG
Bulgaria
Prior art keywords
enyl
phenoxy
diphenyl
chloro
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
BG104713A
Other languages
English (en)
Other versions
BG64471B1 (bg
Inventor
Marja-Liisa Soedervall
Arja Kalapudas
Antti Vitanen
Eero Maentylae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Corp
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of BG104713A publication Critical patent/BG104713A/bg
Publication of BG64471B1 publication Critical patent/BG64471B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Изобретението се отнася до Е-2-[4-(4-хлоро-1,2-дифенил-бут-1-енил)фенокси]етанол, който се използваза понижаване на серумен холестерол, и до фармацевтични състави, които го съдържат както и до методза понижаване на серумен холестерол и до метод запрофилактика или лечение на атеросклероза.
BG104713A 1998-02-19 2000-08-28 Е-2-[4-(4-хлоро-1,2-дифенил-бут-1-енил) фенокси]-етанол и негови фармацевтични състави BG64471B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9803521.5A GB9803521D0 (en) 1998-02-19 1998-02-19 New compounds and pharmaceutical compositions thereof

Publications (2)

Publication Number Publication Date
BG104713A true BG104713A (bg) 2001-03-30
BG64471B1 BG64471B1 (bg) 2005-04-30

Family

ID=10827263

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104713A BG64471B1 (bg) 1998-02-19 2000-08-28 Е-2-[4-(4-хлоро-1,2-дифенил-бут-1-енил) фенокси]-етанол и негови фармацевтични състави

Country Status (33)

Country Link
US (1) US6395785B1 (bg)
EP (1) EP1056701B1 (bg)
JP (1) JP2002503713A (bg)
KR (1) KR100755918B1 (bg)
CN (1) CN1161314C (bg)
AR (1) AR014961A1 (bg)
AT (1) ATE252531T1 (bg)
AU (1) AU755798B2 (bg)
BG (1) BG64471B1 (bg)
BR (1) BR9907688A (bg)
CA (1) CA2321122C (bg)
CZ (1) CZ294315B6 (bg)
DE (1) DE69912247T2 (bg)
DK (1) DK1056701T3 (bg)
EA (1) EA002919B1 (bg)
EE (1) EE04233B1 (bg)
ES (1) ES2211038T3 (bg)
GB (1) GB9803521D0 (bg)
GE (1) GEP20022794B (bg)
HR (1) HRP20000545A2 (bg)
HU (1) HUP0101354A3 (bg)
ID (1) ID26857A (bg)
IL (1) IL137214A (bg)
NO (1) NO325595B1 (bg)
NZ (1) NZ505637A (bg)
PL (1) PL193315B1 (bg)
PT (1) PT1056701E (bg)
RS (1) RS49660B (bg)
SK (1) SK285940B6 (bg)
TR (1) TR200002037T2 (bg)
UA (1) UA57132C2 (bg)
WO (1) WO1999042427A1 (bg)
ZA (1) ZA991232B (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW593256B (en) * 1999-11-16 2004-06-21 Hormos Medical Oy Ltd Triphenylalkene derivatives and their use as selective estrogen receptor modulators
SI1235776T1 (sl) * 1999-11-16 2006-06-30 Hormos Medical Corp Trifenilalkenski derivati in njihova uporaba kot selektivni estrogenski receptorski modulatorji
US20040248989A1 (en) 2003-06-05 2004-12-09 Risto Santti Method for the treatment or prevention of lower urinary tract symptoms
CN101448490A (zh) 2006-05-22 2009-06-03 霍尔莫斯医疗有限公司 治疗慢性非细菌性前列腺炎的选择性雌激素受体调节剂或者芳香酶抑制剂
EP2121553B1 (en) 2007-02-14 2012-06-27 Hormos Medical Ltd. Method for the preparation of therapeutically valuable triphenylbutene derivatives
US7504530B2 (en) 2007-02-14 2009-03-17 Hormos Medical Ltd. Methods for the preparation of fispemifene from ospemifene
CN102770402B (zh) 2010-01-19 2016-01-20 坎布雷卡尔斯库加公司 制造二苯甲酮衍生物的新方法
JP6174156B2 (ja) 2012-10-19 2017-08-02 フェルミオン オサケ ユキチュア オスペミフェンの製造方法
US20150321983A1 (en) * 2012-10-19 2015-11-12 Fermion Oy A process for the preparation of ospemifene
CN104030896A (zh) * 2013-03-07 2014-09-10 天津药物研究院 一种简易去除欧司哌米芬特异杂质的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2126576B (en) 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives
GB9418067D0 (en) 1994-09-07 1994-10-26 Orion Yhtymae Oy Triphenylethylenes for the prevention and treatment of osteoporosis
GB9604577D0 (en) * 1996-03-04 1996-05-01 Orion Yhtymae Oy Serum cholesterol lowering agent

Also Published As

Publication number Publication date
SK285940B6 (sk) 2007-11-02
HRP20000545A2 (en) 2001-02-28
YU51000A (sh) 2002-11-15
PL193315B1 (pl) 2007-01-31
IL137214A0 (en) 2001-07-24
US6395785B1 (en) 2002-05-28
CA2321122A1 (en) 1999-08-26
DE69912247T2 (de) 2004-07-29
CZ294315B6 (cs) 2004-11-10
EP1056701A1 (en) 2000-12-06
EE04233B1 (et) 2004-02-16
BG64471B1 (bg) 2005-04-30
ZA991232B (en) 1999-09-17
JP2002503713A (ja) 2002-02-05
UA57132C2 (uk) 2003-06-16
HUP0101354A3 (en) 2002-05-28
PL342445A1 (en) 2001-06-04
ATE252531T1 (de) 2003-11-15
KR20010040985A (ko) 2001-05-15
TR200002037T2 (tr) 2001-02-21
EP1056701B1 (en) 2003-10-22
NZ505637A (en) 2002-10-25
NO20003987D0 (no) 2000-08-07
CN1161314C (zh) 2004-08-11
AR014961A1 (es) 2001-04-11
ES2211038T3 (es) 2004-07-01
PT1056701E (pt) 2004-03-31
GB9803521D0 (en) 1998-04-15
WO1999042427A1 (en) 1999-08-26
KR100755918B1 (ko) 2007-09-06
GEP20022794B (en) 2002-09-25
CZ20002927A3 (cs) 2000-12-13
DE69912247D1 (de) 2003-11-27
CA2321122C (en) 2008-02-12
IL137214A (en) 2005-05-17
NO325595B1 (no) 2008-06-23
EA200000851A1 (ru) 2001-02-26
SK12052000A3 (sk) 2001-01-18
BR9907688A (pt) 2000-11-14
AU2524499A (en) 1999-09-06
HUP0101354A2 (hu) 2002-03-28
EA002919B1 (ru) 2002-10-31
RS49660B (sr) 2007-09-21
AU755798B2 (en) 2002-12-19
CN1291178A (zh) 2001-04-11
EE200000473A (et) 2001-12-17
ID26857A (id) 2001-02-15
DK1056701T3 (da) 2004-02-02
NO20003987L (no) 2000-08-07

Similar Documents

Publication Publication Date Title
BG101354A (bg) Стеролни състави от осапунена пулпа и тяхното използване
WO1996009827A3 (en) Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor
CA2248032A1 (en) Serum cholesterol lowering agent
BG103190A (bg) Заместени пиримидинови производни и тяхната фармацевтична употреба
BG101209A (bg) Хиполипидемични 1,4-бензотиазепин-1,1-диоксиди
AU6397598A (en) Composition containing moisture regulators for tissue products, process for the production of these products, use of the composition for the treatment of tissue products as well as tissue products in the form of wet-laid, including TAD, or air-laid products (non wovens) on the basis of sheet-like support materials containing primarily cellulose fibers
EP0179559A3 (en) Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
MX9803447A (es) 2-azetidinonas substituidas con azucares, utiles como agentes hipocolesterolemicos.
AU7315987A (en) Trans- (2-(3 or 4-carboxamido-substituted pyrrol-1-yl) alkyl)-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
BG105432A (bg) МЕТОД ЗА ЛЕЧЕНИЕ НА АТЕРОСКЛЕРОЗА ЧРЕЗ ИЗПОЛЗВАНЕНА aP2 ИНХИБИТОР И КОМБИНАЦИЯ
CA2356158A1 (en) Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
BG104713A (bg) Е-2-[4-(4-хлоро-1,2-дифенил-бут-1-енил) фенокси]-етанол и негови фармацевтични състави
WO1999005096A3 (en) Urokinase inhibitors
AU1562895A (en) Process for making xanthene or cubane based compounds, and protease inhibitors
CA2347117A1 (en) Methods for inhibiting diabetic complications
WO1996032109A3 (en) Levobupivacaine and its use as an anaesthetic in pregnant women
AU3950095A (en) Compositions and methods for detection of 2,4-dichlorophenoxyacetic acid and related compounds
BG104958A (bg) Стабилни състави, съдържащи левосимендан и алгинова киселина
AU9465298A (en) Process for reducing the content of cholesterol in dairy products
AU4542897A (en) Process for dechroming, and/or depleting the MgO content of, steel slags
AU4388899A (en) Novel compositions for the treatment of atherosclerosis and related conditions
ZA200103910B (en) 1,4-Diaryl-2-fluoro-1-buten-3-ol compounds and their use in the preparation of 1,4-diaryl-2-fluoro-1,3-butadiene and 1,4-diaryl-2-fluoro-2-butene compounds.
SI1056701T1 (en) E-2- 4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol and pharmaceutical compositions thereof